🔗 Permalink

Assignee profile:

Oncotherapy Science, Inc.

City:

Country:

Japan

Published Applications:

Last publication date:

2014-05-22

Patent Grants:

Last grant date:

2015-06-30

Top Inventors for applications by Oncotherapy Science, Inc.

These are the the leading inventors for applications assigned to Oncotherapy Science, Inc.:

Yusuke Nakamura 5 Tokyo, Japan
Shuichi Nakatsuru 4 Kanagawa, Japan
Takuya Tsunoda 3 Kanagawa, Japan
Takuya Tsunoda 2 Minato-ku, Japan

Hideaki Tahara 2 Meguro-ku, Japan
Sachiko Yoshimura 2 Kanagawa, Japan
Satoshi Wada 2 Meguro-ku, Japan
Ryuji Ohsawa 2 Kanagawa, Japan

Yataro Daigo 2 Tokyo, Japan
Yusuke Nakamura 2 Bunkyo-ku, Japan
Takuya Tsunoda 2 Kawasaki, Japan
Shuichi Nakatsuru 1 Kawasaki, Japan

Yuichi Iwai 1 Tokyo, Japan
Sachiko Yoshimura 1 Kawasaki-shi, Japan
Hideaki Tahara 1 Tokyo, Japan
Motoki Kuhara 1 Aichi, Japan

Midori Shinohara 1 Aichi, Japan
Hideaki Tahara 1 Bunkyo-ku, Japan
Yoichi Furukawa 1 Bunkyo-ku, Japan
Ryuji Ohsawa 1 Kawasaki-shi, Japan

Ryuji Ohsawa 1 Kawasaki, Japan
Satoshi Matsushima 1 Kanagawa, Japan
Kouji Yoshida 1 Kanagawa, Japan
Shiyo Nishida 1 Aichi, Japan

Megumi Yoshikawa 1 Kanagawa, Japan
Toyomasa Katagiri 1 Tokyo, Japan
Shinichi Hiroshima 1 Kanagawa, Japan
Yoshiro Kishi 1 Aichi, Japan

Oncotherapy Science, Inc. 1 Kanagawa, Japan
Youchi Furukawa 1 Tokyo, Japan
Toyomasa Katagiri 1 Bunkyo-ku, Japan
Sachiko Yoshimura 1 Kawasaki, Japan

Takuya TSUNODA 1 Kawasaki-shi, Japan
Satoshi Matsushima 1 Kawasaki, Japan

Recent patent applications by Oncotherapy Science, Inc.

Oncotherapy Science, Inc. based in , JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-05-22 ✅ Patent 9,067,973 granted on 2015-06-30

US20140141027A1

Chemistry; metallurgy

Peptide vaccines for cancers expressing tumor-associated antigens

#2 | 2013-07-25 ✅ Patent 8,759,481 granted on 2014-06-24

US20130189291A1

Chemistry; metallurgy

Peptide vaccines for cancers expressing tumor-associated antigens

#3 | 2013-01-31 ✅ Patent 8,574,585 granted on 2013-11-05

US20130028923A1

Human necessities

KDR peptides and vaccines comprising the same

#4 | 2012-12-27 ✅ Patent 8,574,586 granted on 2013-11-05

US20120328636A1

Human necessities

KDR peptides and vaccines comprising the same

#5 | 2012-12-20 ✅ Patent 8,623,829 granted on 2014-01-07

US20120321649A1

Chemistry; metallurgy

Peptide vaccines for cancers expressing tumor-associated antigens

#6 | 2012-01-26 ✅ Patent 8,771,963 granted on 2014-07-08

US20120021946A1

Chemistry; metallurgy

Method of diagnosing esophageal cancer

#7 | 2011-06-30 ✅ Patent 9,073,021 granted on 2015-07-07

US20110160700A1

Performing operations; transporting

Device and method for automatically preparing emulsion drug

#8 | 2011-03-31 ✅ Patent 8,709,731 granted on 2014-04-29

US20110076280A1

Chemistry; metallurgy

DKK1 oncogene as therapeutic target for cancer and a diagnosing marker

#9 | 2009-08-27 ✅ Patent 8,642,724 granted on 2014-02-04

US20090214571A1

Physics

Colon cancer related gene TOM34

#10 | 2009-08-13 ✅ Patent 8,795,976 granted on 2014-08-05

US20090202543A1

Chemistry; metallurgy

Gene and polypeptide relating to breast cancer

#11 | 2009-07-30 ✅ Patent 8,003,098 granted on 2011-08-23

US20090191211A1

Chemistry; metallurgy

Methods for damaging cells using effector functions of anti-EphA4 antibodies

AssigneeID:

442783 ⎘